Correlation Between NuVasive and Bruker
Can any of the company-specific risk be diversified away by investing in both NuVasive and Bruker at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining NuVasive and Bruker into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between NuVasive and Bruker, you can compare the effects of market volatilities on NuVasive and Bruker and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in NuVasive with a short position of Bruker. Check out your portfolio center. Please also check ongoing floating volatility patterns of NuVasive and Bruker.
Diversification Opportunities for NuVasive and Bruker
Pay attention - limited upside
The 3 months correlation between NuVasive and Bruker is 0.0. Overlapping area represents the amount of risk that can be diversified away by holding NuVasive and Bruker in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Bruker and NuVasive is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on NuVasive are associated (or correlated) with Bruker. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Bruker has no effect on the direction of NuVasive i.e., NuVasive and Bruker go up and down completely randomly.
Pair Corralation between NuVasive and Bruker
If you would invest (100.00) in NuVasive on December 29, 2024 and sell it today you would earn a total of 100.00 from holding NuVasive or generate -100.0% return on investment over 90 days.
Time Period | 3 Months [change] |
Direction | Flat |
Strength | Insignificant |
Accuracy | 0.0% |
Values | Daily Returns |
NuVasive vs. Bruker
Performance |
Timeline |
NuVasive |
Risk-Adjusted Performance
Very Weak
Weak | Strong |
Bruker |
NuVasive and Bruker Volatility Contrast
Predicted Return Density |
Returns |
Pair Trading with NuVasive and Bruker
The main advantage of trading using opposite NuVasive and Bruker positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if NuVasive position performs unexpectedly, Bruker can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Bruker will offset losses from the drop in Bruker's long position.The idea behind NuVasive and Bruker pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Global Correlations module to find global opportunities by holding instruments from different markets.
Other Complementary Tools
USA ETFs Find actively traded Exchange Traded Funds (ETF) in USA | |
Analyst Advice Analyst recommendations and target price estimates broken down by several categories | |
Portfolio Holdings Check your current holdings and cash postion to detemine if your portfolio needs rebalancing | |
Commodity Directory Find actively traded commodities issued by global exchanges | |
Bonds Directory Find actively traded corporate debentures issued by US companies |